Vertis Biotechnologie AG
Biotechnology
-
Short facts
-
- Manufacturer
- Year founded 2000
- 4 Employees (site)
- Turnover: <5m EUR
Products/services: VERTIS is a privately owned research service company with a focus on RNA sequencing and gene regulation analysis. Functional Genomics / Proteomics, Agrobiotechnology, Chip / Array Technology
Basic data
Company
Vertis Biotechnologie AG
Street
Lise-Meitner-Str. 30
PC / City
85354 Freising
County
Upper Bavaria
Phone
+49 8161 18516-11
Fax
+49 8161 18516-12
Homepage
Language skills
English
Profile/competences
Core competencies
Founded 2000, vertis Biotechnologie AG is a research-orientated company in the field of functional genomics. vertis offers innovative tools for rapid identification of candidate genes employing straightforward gene enrichment strategies. These strategies translate into reduction of redundancy when looking at whole transcriptomes or removal of non target sequences allowing to focus on the genes of relevance. Thus, the technology platform of vertis significantly reduces time and costs for downstream gene analyses. The technology is coupled with increased sensitivity enabling the analysis of the transcriptome in as few as 100 cells. The application of the technology is examined in co-operations with research institutes and industrial partners. The aim is the development of DNA-based diagnostic kits for animal and human health care, for plant breeding and plant protection as well as the genomic-based discovery of new drugs and plant protective agents. The company participates in research projects and offers its platform technology as service.
Key sectors / sub-sectors
- Biotechnology: Food and nutrition (incl. diagnostics)
- Biotechnology: Molecular diagnostics for humans
NACE industries
- Manufacture of pesticides and other agrochemical products 20.2
- Manufacture of pharmaceutical preparations 21.2
- Research and experimental development on natural sciences and engineering 72.1
Certifications
not available
Sales markets - target industries
not available
Sales markets - target countries
not available
Cooperation offers
not available